Puffer Sales

Discussion in 'Avanir Pharmaceuticals' started by anonymous, Jul 26, 2016 at 10:41 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    You mean it's not legal to have the mob run dummy scripts for cash to boost my
    Onzetra goal attainment
     

  2. anonymous

    anonymous Guest

    I was under the impression that a
    Script we get credit for only counts
    When the patient pays fully for the
    Med and picks up from the pharmacy.
    In the case of dummy scripts those
    Wouldn't lower product inventory so
    no credit would be given.
     
  3. anonymous

    anonymous Guest

    Obviously you don't understand
    Money laundering and dummy scripts

    Call the mob and they'll explain

    Script credit is being given
     
  4. anonymous

    anonymous Guest

    So the script is actually being filled
    with cash paying customers ?
    Do the co pay cards work ?
     
  5. anonymous

    anonymous Guest

    As of today, there are 75 reps
    who have 13 or less scripts
    in the quarter with 3 weeks of
    sales left in the quarter.
     
  6. anonymous

    anonymous Guest

    Update - Q1 has ended and 90
    reps out of 220 have less than
    20 Onzetra scripts for the quarter.
    And 44 reps out of 220 made their
    Onzetra baseline goal or above.
    So 176 reps will make 0 dollars
    on Onzetra.
     
  7. anonymous

    anonymous Guest

    Avanir has been screwing us out of our scripts
    Every week my providers are telling me they submitted a bunch of scripts and showed me evidence but nothing is showing up
    Avanir doesn't want to pay
    This company is very shady
    Time to get out before the downsizing starts
     
  8. anonymous

    anonymous Guest

    When do you think the downsizing will
    start ?
    How bad will it hit the NAMS,
    we only have 200 reps for the
    entire country with 2 products ?
     
  9. anonymous

    anonymous Guest

    Bad; it will be under 100 when they finish up with Avanir.
     
  10. anonymous

    anonymous Guest

    Lol. Hind sight......but, omg. More evidence that most pharma managers are in fact, dumb asses who imitate business Leaders.
     
  11. anonymous

    anonymous Guest

    Which simply means, dip.....t. Many Ad Board, opinion leaders, researchers, faculty, even PAID speakers know some products are marginal value propositions.
     
  12. anonymous

    anonymous Guest

    I'm sure some reps and DA "manager" is or are or have run a business. But lmao. If you can't MAKE $50MM net let alone gross. Go home. It's marginal value TODAY. Unless your promoting it OFF LABEL. Oh, "you" have and still do in weak, unethical moments.
     
  13. anonymous

    anonymous Guest

    Give that gal or guy a job in the biggest cottage industry since '05, your ever growing and FAILING pharmaceutical legal compliance teams.
     
  14. anonymous

    anonymous Guest

    Haha

    And if the lawyers were all out policing the sales more crimes would be committed albeit in elegant circumvented machination. But no less legal than a dumb rep running to people in the Midwest saying try this in people under 18. Just more "defensible".

    EOD, pathetic discipline across the board with weak products that rightly have poor insurance coverage.

    But hey, $$$,$$$,$$$ is God. So, who gets paid next?
     
  15. anonymous

    anonymous Guest

    The Puffer works great with Weed, thats why sales are strong in California
     
  16. anonymous

    anonymous Guest

    Is that why Puffer sales are strong
    in Buffalo?
    Or I guess it might be because of
    the Buffalo rep ?
     
  17. anonymous

    anonymous Guest

    Dent Headache Institute
    8 Clinical Trial Investigstors
    8 Paid Speakers
     
  18. anonymous

    anonymous Guest

    Dent is definitely pay to play.

    Doesn't matter who the rep is.
     
  19. anonymous

    anonymous Guest

    We are returning the rights to this dud next quarter.
     
  20. anonymous

    anonymous Guest

    Did you get that info from Paul
    or CNN ?